title: Differentiating opioids by their pupillary effects in the rat.
abstract: Pupillary effects of several opioids were examined as part of a broader in vivo study of multiple opioid receptors in the rat. Agonist activity, stereospecificity, and naloxone sensitivity were determined by methadone (Me), ethylketocyclazocine (EK), and N-allylnormetazocine (SKF 10,047), selected for their purportedly predominant actions at mu, kappa, and sigma receptors, respectively. After an acute, subcutaneous injection of each drug, pupil area and fluctuations in pupil size were measured by means of an infrared video pupillometer on line with a microcomputer data processing and storage system. Despite differences in the magnitude of the response, each opioid tested produced an increase in pupil size which was stereospecific, independent of behavioral responses to the drugs and, for 1-Me and 1-SKF 10,047, dose-related. Other differences among the opioids were found in their ability to induce fluctuations (1-Me and 1-EK) and a pendular nystagmus (1-SKF 10,047 only), and in their sensitivity to naloxone. Although 1.0 mg/kg naloxone completely reversed 1-Me-induced mydriasis, 10 mg/kg was needed to reverse 1-EK, and this dose only partially antagonized 1-SKF 10,047. These characteristic patterns of pupillary responses to opioids in terms of agonist activities and naloxone sensitivities indicate that the different opioid receptor types subserve different functions with respect to pupillary control.
authors.forename: M
authors.initials: M
authors.lastname: Robin
authors.forename: A
authors.initials: A
authors.lastname: Kirby
authors.forename: S
authors.initials: S
authors.lastname: Messner
authors.forename: E B
authors.initials: EB
authors.lastname: Geller
authors.forename: M W
authors.initials: MW
authors.lastname: Adler
mesh_terms: D000818:Animals; D003496:Cyclazocine / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D016314:Ethylketocyclazocine; D008297:Male; D008691:Methadone / Q000037:antagonists & inhibitors / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects; D009270:Naloxone / Q000494:pharmacology; D009294:Narcotics / Q000145:classification* / Q000494:pharmacology; D009760:Nystagmus, Physiologic / Q000187:drug effects; D010620:Phenazocine / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors / Q000494:pharmacology; D011680:Pupil / Q000187:drug effects*; D051381:Rats; D011919:Rats, Inbred Strains; D011957:Receptors, Opioid / Q000145:classification / Q000187:drug effects; D013237:Stereoisomerism
chemical_list: D009294:Narcotics; D011957:Receptors, Opioid; D009270:Naloxone; D016314:Ethylketocyclazocine; C012134:SK&F 10047; D010620:Phenazocine; D003496:Cyclazocine; D008691:Methadone